A Thai plant-based pharmaceutical company has produced antibodies against cancer from tobacco and undertaken successful trials using lab animals, it said.
Baiya Phytopharm, a start-up under the auspices of Chulalongkorn University, is known for its Baiya Sars-CoV-2 Vax, a plant-based vaccine against Covid-19.
However, the company says it recently reached a new milestone in immunotherapy.